Ablation vs Medication as Initial Therapy for Paroxysmal Atrial Fibrillation: An Updated Meta-Analysis of Randomized Controlled Trials
Jakrin Kewcharoen MD1, Narut Prasitlumkum MD2, Ronpichai Chokesuwattanaskul MD3, Ruiyang Yi4, Krit Jongnarangsin MD5, T Jared Bunch MD6, Ravi Ranjan, MD PhD6, Leenhapong Navaravong MD6
1) University of Hawaii Internal Medicine Residency Program, Honolulu, HI, USA
2) Division of Cardiology, University of California Riverside School of Medicine, Riverside, California, USA
3) Division of Cardiology, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand
4) Department of Internal Medicine, John A. Burns School of Medicine, Honolulu, HI, USA
5) Division of Cardiovascular Medicine, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA
6) Division of Cardiovascular Medicine, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA
Running head: Ablation as initial therapy for paroxysmal atrial fibrillation
Keywords: atrial fibrillation ablation, first line therapy, paroxysmal atrial fibrillation
Acknowledgement: None
Financial support: None
Conflict of Interest : All authors declare no conflict of interest